Grant winners

九月 15, 2011


Health Technology Assessment

(NIHR HTA) programme

• Award winner: Charles Knowles

• Institution: Barts and the London School of Medicine and Dentistry

• Value: £529,685

Control of faecal incontinence using distal neuromodulation


Research Fellowships

• Award winner: Elizabeth Archibald

• Institution: University of Bristol

Baths and bathing in medieval literature and society

• Award winner: M. Niaz Asadullah

• Institution: University of Reading

The rise of Islamic schools in Bangladesh

• Award winner: David Attwell

• Institution: University of York

J.M. Coetzee: a political life

• Award winner: Estella Baker

• Institution: University of Sheffield

The EU as a penal actor: an investigation of policymaking and governance

• Award winner: Daniel Beer

• Institution: Royal Holloway, University of London

In the depths of Siberia's mines: exile and penal labour in Russia, 1822-1917

• Award winner: Christine Bell

• Institution: University of Edinburgh

Talking about international constitutional law

• Award winner: Debopam Bhattacharya

• Institution: University of Oxford

Subsidised provision of health products with social benefits

• Award winner: Johnston Birchall

• Institution: University of Stirling

Risk and regulation after the banking crisis: harnessing the potential of customer-owned banks

Research Project Grants

• Award winner: Robert G. Endres

• Institution: Imperial College London

• Value: £171,897

Learning and kinetic proofreading for chemical sensing beyond the physical limit

• Award winner: Christophe Aissa

• Institution: University of Liverpool

• Value: £102,324

Molecular hybrids to determine the binding mode of extracellular actin on the surface of cells

Economics, business studies, industrial relations

• Award winner: Xiaohui Liu

• Institution: Loughborough University

• Value: £43,429

CEO compensation, subnational institutions and firm internationalisation

In Detail

• Award winner: Mark Drayson

• Institution: University of Birmingham

• Value: £1,942,789

Tackling early morbidity and mortality in myeloma: assessing the benefits of antibiotic prophylaxis and its effect on healthcare-associated infections

There is a high risk of infection in patients with impaired immune function. Giving these patients antibiotic prophylaxis (AP) is common practice in the NHS. Studies that established the benefit of AP, however, were done before the current rise in healthcare-associated infections. There is an urgent need to study the risks of AP therapy with respect to its effect on carriage rates of infectious organisms. Myeloma is a cancer of bone marrow plasma cells and causes very low immunity, with infections in a quarter of patients. This study will investigate the benefit of antibiotic treatment of myeloma sufferers. The team will assess risks, benefits and cost-effectiveness of antibiotic prophylaxis in newly diagnosed symptomatic myeloma.



  • 注册是免费的,而且十分便捷
  • 注册成功后,您每月可免费阅读3篇文章
  • 订阅我们的邮件
Please 登录 or 注册 to read this article.